Table 2.
Number of Animals Used in the Study
| Mouse Group | N | Age (Postnatal Days) |
|---|---|---|
| ERG analysis of retinal function | ||
| WT | 6 | 35 |
| rd10 | 7 | 35 |
| rd10 (0.5 mg kg-1 (+)-PTZ) | 7 | 35 |
| rd10 (1 mg kg-1 SA4503) | 4 | 35 |
| rd10 (0.5 mg kg-1 PRE084) | 4 | 35 |
| OCT analysis of retinal structure | ||
| WT | 6 | 42 |
| rd10 | 7 | 42 |
| rd10 (0.5 mg kg-1 (+)-PTZ) | 7 | 42 |
| rd10 (1 mg kg-1 SA4503) | 4 | 42 |
| rd10 (0.5 mg kg-1 PRE084) | 4 | 42 |
| OptoMotry analysis of vision acuity | ||
| WT | 6 | 21 |
| rd10 | 7 | 21 |
| rd10 (0.5 mg kg-1 (+)-PTZ) | 7 | 21 |
| rd10 (1 mg kg-1 SA4503) | 4 | 21 |
| rd10 (0.5 mg kg-1 PRE084) | 4 | 21 |
| WT | 6 | 28 |
| rd10 | 7 | 28 |
| rd10 (0.5 mg kg-1 (+)-PTZ) | 7 | 28 |
| rd10 (1 mg kg-1 SA4503) | 4 | 28 |
| rd10 (0.5 mg kg-1 PRE084) | 4 | 28 |
| WT | 6 | 41 |
| rd10 | 7 | 41 |
| rd10 (0.5 mg kg-1 (+)-PTZ) | 7 | 41 |
| rd10 (1 mg kg-1 SA4503) | 4 | 41 |
| rd10 (0.5 mg kg-1 PRE084) | 4 | 41 |